Citation Impact
Citing Papers
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels
2006 StandoutNobel
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro
1996
Annexin II is the membrane receptor that mediates the rapid actions of 1?,25-dihydroxyvitamin D3
2000
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
1991 Standout
1,25-Dihydroxyvitamin D3 Inhibits Osteocalcin Expression in Mouse through an Indirect Mechanism
1997
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
2002 Standout
Kidney stones: pathophysiology and medical management
2006 Standout
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
The spectrum of bone disease in end-stage renal failure—An evolving disorder
1993
Arachidonic acid in cell signaling
1993
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
The β-Thalassemias
1999 Standout
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Therapeutic uses of vitamin D analogues
2001
Magnesium and its alloys as orthopedic biomaterials: A review
2005 Standout
Evidence for distinct membrane receptors for 1α,25-(OH)2D3 and 24R,25-(OH)2D3 in osteoblasts
2002
The genetic transformation of bone biology
1999
Vitamin D Deficiency
2007 Standout
Clinical Pharmacokinetics in Organ Transplant Patients
1989
An essential role for Rxrα in the development of Th2 responses
2005 StandoutNobel
Identification of an Allosteric Binding Site for Zn2+on the β2 Adrenergic Receptor
2002 StandoutNobel
Osteoporosis: now and the future
2011 Standout
Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients
2003
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
1997 Standout
Allosteric Modulation of β2-Adrenergic Receptor by Zn2+
2002 StandoutNobel
Follow-up of five patients with FHHNC due to mutations in the Paracellin-1 gene
2002
Parathyroid Hormone 7-84 Induces Hypocalcemia and Inhibits the Parathyroid Hormone 1-84 Secretory Response to Hypocalcemia in Rats with Intact Parathyroid Glands
2006
Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone
2005
Maternal and child undernutrition: global and regional exposures and health consequences
2008 Standout
Benefits and drawbacks of zinc in glass ionomer bone cements
2011
The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation
2002 Standout
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Renal Osteodystrophy, Phosphate Homeostasis, and Vascular Calcification
2007
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Resurrection of vitamin D deficiency and rickets
2006
Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients.
1992
CLINICAL COUNTERPOINT: Vitamin D: New Actions, New Analogs, New Therapeutic Potential*
1992
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
2004 Standout
Polyphenols: food sources and bioavailability
2004 Standout
Enhanced functions of osteoblasts on nanophase ceramics
2000 Standout
Vitamin D
2005
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Importance of arachidonic acid as a mediator of parathyroid gland response
2003
Bone disease in children with homozygous β-thalassemia
1990
Degradative processes of connective tissue proteins with special emphasis on collagenolysis and bone resorption
1988
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
2004 Standout
Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism
2005
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
Acute toxicity of metal ions in cultures of osteogenic cells derived from bone marrow stromal cells
1995
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism
2010
Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic Hypercalciuria
2002 Standout
Calcitonin Simultaneously Regulates Both Periosteal Hyperostosis and Trabecular Osteopenia in the Spinal Hyperostotic Mouse (twy/twy) In Vivo
1999
Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis
1996
Demographic and geographic variability of kidney stones in the United States
1994
The Calcium-Sensing Receptor: Physiology, Pathophysiology and Car-Based Therapeutics
2007
Involvement of calcium-sensing receptor in ischemia/reperfusion-induced apoptosis in rat cardiomyocytes
2006
Bone demineralization induced by cementless alumina-coated femoral stems
1994
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
2003 StandoutNature
Chronic Kidney Disease
2016 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Cooperative multi-modal sensing and therapeutic implications of the extracellular Ca2+ sensing receptor
2000
Leptin Inhibits Bone Formation through a Hypothalamic Relay
2000 Standout
Genetic Hypercalciuria
2005
Normalization of Mineral Ion Homeostasis by Dietary Means Prevents Hyperparathyroidism, Rickets, and Osteomalacia, But Not Alopecia in Vitamin D Receptor-Ablated Mice1
1998
Vitamin D deficiency: a worldwide problem with health consequences
2008 Standout
Trace Element Nutrition and Bone Metabolism
1992
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
2011 Standout
Post-renal transplantation hypophosphatemia: a review and novel insights
2006
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
TREATMENT OF DIALYSIS OSTEOMALACIA WITH DESFERRIOXAMINE
1982
Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent.
1984 StandoutNobel
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization
2002 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
1995 Standout
Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia
1997
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
1998
Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health
2002
Binding of 1α,25‐dihydroxyvitamin D 3 to annexin II: Effect of vitamin D metabolites and calcium
2000
Nongenomic Steroid Action: Controversies, Questions, and Answers
2003
Integrins and Signal Transduction Pathways: the Road Taken
1995 StandoutScience
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Cell signaling and estrogens in female rat osteoblasts: A possible involvement of unconventional nonnuclear receptors
1993
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses1
1999
Normalization of Mineral Ion Homeostasis by Dietary Means Prevents Hyperparathyroidism, Rickets, and Osteomalacia, But Not Alopecia in Vitamin D Receptor-Ablated Mice
1998
Evidence for Disordered Control of 1,25-Dihydroxyvitamin D Production in Absorptive Hypercalciuria
1984
Phosphate Regulation of Vascular Smooth Muscle Cell Calcification
2000 Standout
Vitamin D
1999
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Controls of Hair Follicle Cycling
2001 Standout
Annexins: From Structure to Function
2002 Standout
Carrier-Based Ion-Selective Electrodes and Bulk Optodes. 2. Ionophores for Potentiometric and Optical Sensors
1998 Standout
Theory and applications of ion-selective electrodes part II
1977
Vitamin D deficiency in obesity and health consequences
2006
The Vitamin D Endocrine System: Steroid Metabolism, Hormone Receptors, and Biological Response (Calcium Binding Proteins)*
1982
Bone metabolism and disease in chronic kidney disease
2003
Physiology of Microglia
2011 Standout
Oxygen toxicity, oxygen radicals, transition metals and disease
1984 Standout
Extracellular Calcium Sensing and Extracellular Calcium Signaling
2001
Maternal-Fetal Calcium and Bone Metabolism During Pregnancy, Puerperium, and Lactation*
1997
Works of A. Bourdeau being referenced
Effect of calcitonin administration on young pig trabecular bone remodeling
1990
Autocrine Regulation of Parathyroid Secretion: Inhibition of Secretion by Chromogranin-A (Secretory Protein-I) and Potentiation of Secretion by Chromogranin-A and Pancreastatin Antibodies*
1990
Rapid Effects of 1,25-Dihydroxyvitamin D3and Extracellular Ca2+on Phospholipid Metabolism in Dispersed Porcine Parathyroid Cells
1990
Human parathyroid cell proliferation in response to calcium, NPS R‐467, calcitriol and phosphate
2001
Bone ultrastructure and x-ray microanalysis of aluminum-intoxicated hemodialyzed patients
1984
Total Parathyroidectomy and Delayed Parathyroid Autotransplantation Using a Simplified Cryopreservation Technique: Human and Animal Studies
1984
Oscillations in inositol 1,4,5-trisphosphate and diacyglycerol induced by vitamin D3 metabolites in confluent mouse osteoblasts
1993
Bovine Serum Albumin (BSA)-Calcium Binding Studies with a Calcium Selective Liquid Membrane Electrode
1971
Effect of plasma levels of parathyroid hormone on NADPH pathways in kidney and liver
1985
Secondary hyperparathyroidism in chronic haemodialysis patients: a clinico-pathological study.
1983
Suppressive Effects of 24,25-Dihydroxycholecalciferol on Bone Resorption Induced by Acute Bilateral Nephrectomy in Rats
1981
Effect of aluminum on bone and cell localization.
1986
Effects of lipoxygenase products of arachidonate metabolism on parathyroid hormone secretion.
1994
Phospholipase-A2 action and arachidonic acid metabolism in calcium-mediated parathyroid hormone secretion.
1992
Chronic Hypophosphatemia in Kidney Transplanted Children and Young Adults
1980
Persistence of Ca2+-Sensing Receptor Expression in Functionally Active, Long-Term Human Parathyroid Cell Cultures
1998
Bone modeling in gallium nitrate-treated rats
1987
Effects of Weight and Glucose Ingestion on Urinary Calcium and Phosphate Excretion: Implications for Calcium Urolithiasis
1982
Bioactive parathyroid hormone in pregnant rats and fetuses
1990
Effects of lipoxygenase products of arachidonate metabolism on parathyroid hormone secretion
1994
Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D.
1986
Aluminum localization in bone from hemodialyzed patients: Relationship to matrix mineralization
1981
Renal Magnesium and Phosphate Wastage in a Patient with Hypercalciuria and Nephrocalcinosis: Effect of Oral Phosphorus and Magnesium Supplements
1985